Test whether high dose corticosteroid pulse therapy (HDCPT) with either methylprednisolone or dexamethasone is associated with increased survival in COVID-19 patients at risk of hyper-inflammatory response. Provide some initial diagnostic criteria using laboratory markers to stratify these patients. This is a prospective observational study, 318 met the inclusion criteria. 64 patients (20.1%) were treated with HDCPT by using at least 1.5mg/kg/24h of methylprednisolone or dexamethasone equivalent. A multivariate Cox regression (controlling for co-morbidities and other therapies) was carried out to determine whether HDCPT (among other interventions) was associated with decreased mortality. We also carried out a 30-day time course analysis of ...
Objective: To compare the efficacy of pulsed-dose corticosteroids (≥250 mg methylprednisolone, 3 day...
Low-dose dexamethasone reduces mortality in patients with coronavirus disease 2019 (COVID-19)-relate...
Corticosteroid therapy is now recommended as a treatment in patients with severe COVID-19. But one k...
ObjectiveTest whether high dose corticosteroid pulse therapy (HDCPT) with either methylprednisolone ...
Objective. To assess efficacy and safety of methylprednisolone pulse therapy in patients with COVID...
Objectives. To assess the influence of corticosteroid pulses on 60-day mortality in hospitalized pat...
BackgroundThe success of early dexamethasone therapy for hospitalised COVID-19 cases in treatment of...
Background: the success of early dexamethasone therapy for hospitalised COVID-19 cases in treatment ...
The hyperinflammatory phase represents the main cause for the clinical worsening of acute respirator...
Objective. The results of the RECOVERY trial identified dexamethasone as the first pharmacological t...
Background: the success of early dexamethasone therapy for hospitalised COVID-19 cases in treatment ...
Corticosteroids are largely recommended in patients with severe COVID-19. However, evidence to suppo...
The aim of the study. To compare the effectiveness of methylprednisolone, dexamethasone and tocilizu...
The aim of the study. To compare the effectiveness of methylprednisolone, dexamethasone and tocilizu...
Corticosteroid dosing in the range of 0.5-2 mg/kg/day of methylprednisolone equivalents has become a...
Objective: To compare the efficacy of pulsed-dose corticosteroids (≥250 mg methylprednisolone, 3 day...
Low-dose dexamethasone reduces mortality in patients with coronavirus disease 2019 (COVID-19)-relate...
Corticosteroid therapy is now recommended as a treatment in patients with severe COVID-19. But one k...
ObjectiveTest whether high dose corticosteroid pulse therapy (HDCPT) with either methylprednisolone ...
Objective. To assess efficacy and safety of methylprednisolone pulse therapy in patients with COVID...
Objectives. To assess the influence of corticosteroid pulses on 60-day mortality in hospitalized pat...
BackgroundThe success of early dexamethasone therapy for hospitalised COVID-19 cases in treatment of...
Background: the success of early dexamethasone therapy for hospitalised COVID-19 cases in treatment ...
The hyperinflammatory phase represents the main cause for the clinical worsening of acute respirator...
Objective. The results of the RECOVERY trial identified dexamethasone as the first pharmacological t...
Background: the success of early dexamethasone therapy for hospitalised COVID-19 cases in treatment ...
Corticosteroids are largely recommended in patients with severe COVID-19. However, evidence to suppo...
The aim of the study. To compare the effectiveness of methylprednisolone, dexamethasone and tocilizu...
The aim of the study. To compare the effectiveness of methylprednisolone, dexamethasone and tocilizu...
Corticosteroid dosing in the range of 0.5-2 mg/kg/day of methylprednisolone equivalents has become a...
Objective: To compare the efficacy of pulsed-dose corticosteroids (≥250 mg methylprednisolone, 3 day...
Low-dose dexamethasone reduces mortality in patients with coronavirus disease 2019 (COVID-19)-relate...
Corticosteroid therapy is now recommended as a treatment in patients with severe COVID-19. But one k...